4975-21-7

Usage

Uses

Used in Organic Synthesis:
Dimethylfurazan is used as a key intermediate in the synthesis of various organic compounds. Its reactivity, stemming from the furan ring and methyl substituents, allows for a wide range of chemical transformations, making it a valuable building block in the preparation of pharmaceuticals, agrochemicals, and other specialty chemicals.
Used in Biofuel Production:
As a biofuel, Dimethylfurazan is considered an alternative to traditional fossil fuels. It is derived from renewable resources like cellulosic biomass, offering a more sustainable energy source. The use of Dimethylfurazan as a biofuel contributes to reducing greenhouse gas emissions and dependence on non-renewable energy sources.
Used in Research and Development:
Dimethylfurazan serves as a model compound in academic and industrial research, particularly in the fields of materials science and catalysis. Its unique chemical properties and reactivity make it an ideal candidate for studying reaction mechanisms, exploring new synthetic routes, and developing novel materials with potential applications in various industries.
Used in Safety and Hazard Management:
Given its flammability, Dimethylfurazan is also used in the development and testing of safety protocols and hazard management strategies. Understanding its combustion characteristics and potential risks can inform the design of safer handling procedures and the creation of effective fire prevention measures in laboratories and industrial settings.

InChI:InChI=1/C4H6N2O/c1-3-4(2)6-7-5-3/h1-2H3

Upstream product

• 95-45-4 butane-2,3-dione dioxime 
• 7664-41-7 ammonia 
• 17117-97-4 dimethyl glyoxime 
• 108-30-5 succinic acid anhydride 
• 2518-42-5 3,4-dimethylfurazan-2-oxide 

Downstream Products

• 58677-34-2 4-methyl-1,2,5-oxadiazole-3-carboxylic acid 
• 15323-69-0 (4-methyl-1,2,5-oxadiazol-3-yl)acetic acid 
• 62642-47-1 3-(chloromethyl)-4-methyl-1,2,5-oxadiazole 
• 90507-32-7 3-(bromomethyl)-4-methyl-1,2,5-oxadiazole 
• 53601-88-0 3,4-bis-chloromethyl-furazan 
• 627904-53-4 1-(4-methylfurazan-3-yl)acetone 
• 627904-50-1 3-methyl-4-(2-phenylethyl)furazan 

Relevant academic research and scientific papers

4-[(4-(CARBOXYETHYL) PIPERIDINYL) METHYL] PYRROLIDINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY

3-Substituted pyrrolidines having a 4-carboxypiperidinylmethyl substituent on the 4-position of the ring are useful as modulators of chemokine receptor activity. In particular, these compounds are useful as modulators of the chemokine receptors CCR-3 and/or CCR-5.

4(SPIROPIPERIDINYL)METHYL SUBSTITUTED PYRROLIDINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY

3-Substituted pyrrolidines having a spiropiperidinylmethyl substituent on the 4-position of the ring are useful as modulators of chemokine receptor activity. In particular, these compounds are useful as modulators of the chemokine receptors CCR-3 and/or CCR-5.

Organometallic synthesis in the furazan series 2. Furazanylethanes

The reactions of Li derivatives of methylfurazans with electrophilic reagents and oxidants were investigated. A series of functionalized furazanylethane derivatives were prepared.

MORPHOLINE DERIVATIVES, COMPOSITIONS CONTAINING THEM AND THEIR USE AS THERAPEUTIC AGENTS

The present invention relates to compounds of formula (I), wherein R. sup.1 and R 4 represent hydrogen, halogen, C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 3-7 cycloalkyl, C 3-7 cycloalkylC. sub.1-4 alkyl, C 1-6 alkoxy, C 1-4 alkyl substituted by a hydroxy or C 1-4 alkoxy group, OCF 3, hydroxy, trifluoromethyl, trimethylsilyl, nitro, CN, SR a, SOR a, SO 2 R a, COR. sup.a, CO 2 R a or CONR a R b, where R. sup.a and R b are each independently hydrogen or C 1-4 alkyl; R. sup.2, R 3 and R 5 represent hydrogen, halogen, C 1-6 alkyl, C 1-4 alkoxy substituted by a C 1-4 alkoxy group, or trifluoromethyl; R 6 represents C 1-6 alkyl, optionally substituted by oxo, substituted by a 5-membered heteroaromatic ring selected from oxazole, thiazole, isoxazole, isothiazole, oxadiazole and thiadiazole, wherein each heteroaromatic ring is substituted at the available carbon atom by a group of the formula: ZNR 7 R 8. The compounds are of particular use in the treatment of pain, inflammation, migraine and emesis.